REGENEREX PHARMA, INC.
REGENEREX PHARMA, INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Finite Lived Intangible Assets Net | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | - | - | - | - | 0 | - | - | - | - | - | - | - | |||||
Capitalized Computer Software Gross | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Machinery And Equipment Gross | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | |||||
Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Due To Related Parties Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 1 | 1 | 1 | |||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Employee Related Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | - | - | - | |||||
Notes Payable Current | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Notes Payable | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | 0 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | |||||
Liabilities | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 2 | 1 | 1 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 5 | 4 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -5 | -5 | -4 | -5 | -5 | -4 | -4 | -4 | -4 | -1 | -1 | -1 | |||||
Retained Earnings Accumulated Deficit | -10 | -9 | -8 | -7 | -6 | -6 | -6 | -5 | -5 | -2 | -2 | -2 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | |||||
Common Stock Shares Authorized | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | 675 | |||||
Common Stock Shares Issued | 282 | 281 | 281 | 278 | 278 | 278 | 278 | 278 | 278 | 277 | 277 | 277 | |||||
Shares Outstanding | 282 | 281 | 281 | 278 | 278 | 278 | 278 | 278 | 278 | 277 | 277 | 277 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
REGENEREX PHARMA, INC. (RGPX) — SEC Financial Statements & Analysis
REGENEREX PHARMA, INC. (RGPX) is a pharmaceutical preparations company, incorporated in NV. REGENEREX PHARMA, INC. trades on OTC as: RGPX. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), REGENEREX PHARMA, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.13x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -1.13x
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is REGENEREX PHARMA, INC. in?
REGENEREX PHARMA, INC. (RGPX) operates in the Pharmaceutical Preparations industry.
What exchange does RGPX trade on?
REGENEREX PHARMA, INC. (RGPX) trades on the OTC.
Where is REGENEREX PHARMA, INC. incorporated?
REGENEREX PHARMA, INC. is incorporated in NV.